
Development of zzso zzso zzso reduces the clinical efficacy of zzso beta zzso treatment in multiple sclerosis zzso zzso The aim of this study was to evaluate zzso zzso zzso of patients with zzso and zzso zzso zzso of zzso preparations in a clinical zzso We zzso zzso consecutive zzso patients, treated with one of the three available zzso zzso for an average of 40 months zzso zzso for the presence of zzso with the zzso protein induction zzso Overall, zzso of patients were positive for zzso with zzso zzso above zzso The frequency of zzso zzso the zzso was zzso in zzso patients, zzso for zzso zzso for zzso and zzso for zzso In addition, the potential to induce high zzso levels, zzso the zzso was observed to differ between zzso zzso showing the lowest zzso also showed low zzso and typically induced low zzso zzso showing the highest zzso when inducing zzso induced lower zzso compared to zzso and zzso Treatment duration over five years only marginally correlated with decreased zzso and zzso zzso In conclusion, zzso to zzso are common in a clinical setting and the zzso preparations differ not only in zzso zzso but also in zzso 

